我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
1
0 进行中
药物批准
812
批准总数
监管机构
2
监管机构数
成立时间
N/A
已完成
100.0%
NMPA
National Medical Products Administration
FDA
Food and Drug Administration
811
• The global smart drug delivery systems market reached $12 billion in 2024 and is projected to grow at a CAGR of 17% through 2034, driven by rising chronic disease prevalence and technological advancements. • Connected inhalers are gaining significant traction for respiratory and neurological conditions, with recent partnerships like Modivcare and Tenovi deploying Adherium's Hailie smart inhalers to improve patient care. • Injectable smart delivery systems dominated the market with a $7.6 billion valuation in 2024, while North America leads regional adoption with $5.5 billion in revenue, expected to reach $22.2 billion by 2034.
